Facile synthesis of stereoisomers of the non-secosteroidal ligand LG190178 and their evaluation using the mutant vitamin D receptor

Letters in Organic Chemistry

Volumn 8, Issue 1, 2011, Pages 43-47

  Demizu, Yosuke ^a   Nakatsu, Aki ^a   Sato, Yukiko ^a   Honzawa, Shinobu ^b   Yamashita, Atsushi ^b   Sugiura, Takayuki ^b   Kittaka, Atsushi ^b   Kato, Shigeaki ^c   Okuda, Haruhiro ^a   Kurihara, Masaaki ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Asymmetric reduction; Molecular modeling study.; Mutant vitamin D receptor; Non secosteroidal ligand; Transcriptional assay; Vitamin D receptor

Indexed keywords

EID: 79751501479     PISSN: 15701786     EISSN: None     Source Type: Journal    
DOI: 10.2174/157017811794557804     Document Type: Article

References (27)

1. Bouillon, R.; Okamura, W. H.; Norman, A. W. Structurefunction relationships in the vitamin D endocrine system. Endocr. Rev., 1995, 16, 200-257
2. Feldman, D.; Glorieux, F. H.; Pike, J. W. Vitamin D, 2nd ed.; Elsevier Academic Press, New York, 2005.
3. Ettinger R. A.; Deluca H. F. The vitamin D endocrine system and its therapeutic potential. Adv. Drug. Res., 1996, 28, 269-312 (Pubitemid 26268081)
4. Kubodera, N. Search for and development of active vitamin D3 analogs. Curr. Bioact. Comp., 2006, 2, 301-315.
5. Rochel, N.; Wurtz, J. M.; Mitschler, A.; Klaholz, B.; Moras, D. The Crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol. Cell., 2000, 5, 173-179. (Pubitemid 30105446)
6. Suhara, Y.; Kittaka, A.; Ono, K.; Kurihara, M.; Fujishima, T.; Yoshida, A.; Takayama, H. Design and efficient synthesis of new stable 1α,25-dihydroxy-19-norvitamin D3 analogues containing amide bond. Bioorg. Med. Chem. Lett., 2002, 12, 3533-3536 (Pubitemid 35346483)
7. Kittaka, A.; Kurihara, M.; Peleg, S.; Suhara, Y.; Takayama, H. 2α- (3-Hydroxypropyl)- and 2α-(3-hydroxypropoxy)-1α,25- dihydroxyvitamin D3 accessible to vitamin D receptor mutant related to hereditary vitamin D-resistant rickets. Chem. Pharm. Bull., 2003, 51, 357-358 (Pubitemid 41701977)
8. Honzawa, S.; Suhara, Y.; Nihei, K.; Saito, N.; Kishimoto, S.; Fujishima, T.; Kurihara, M.; Sugiura, T.; Waku, K.; Takayama, H.; Kittaka, A. Concise synthesis and biological activities of 2α-alkyl- and 2α-(ω- hydroxyalkyl)-20-epi-1α,25-dihydroxyvitamin D3. Bioorg. Med. Chem. Lett., 2003, 13, 3503-3506 (Pubitemid 37141417)
9. Saito, N.; Suhara, Y.; Kurihara, M.; Fujishima, T.; Honzawa, S.; Takayanagi, H.; Kozono, T.; Matsumoto, M.; Ohmori, M.; Miyata, N.; Takayama, H.; Kittaka, A. Design and efficient synthesis of 2α-(ω-hydroxyalkoxy)- 1α,25- dihydroxyvitamin D3 analogues, including 2-epi-ED-71 and their 20-epimers with HL-60 cell differentiation activity. J. Org. Chem., 2004, 69, 7463-7471 (Pubitemid 39403331)
10. Honzawa, S.; Hirasaka, K.; Yamamoto, Y.; Peleg, S.; Fujishima, T.; Kurihara, M.; Saito, N.; Kishimoto, S.; Sugiura, T.; Waku, K.; Takayama, H.; Kittaka, A. Design, synthesis and biological evaluation of novel 1α,25- dihydroxyvitamin D3 analogues possessing aromatic ring on 2α-position. Tetrahedron, 2005, 61, 11253-11263. (Pubitemid 41502903)
11. Perakyla, M.; Malinen, M.; Herzig, K. H.; Carlberg, C. Gene regulatory potential of nonsteroidal vitamin D receptor ligands. Mol. Endocrinol., 2005, 19, 2060-2073 (Pubitemid 41124201)
12. Hosoda, S.; Tanatani, A.; Wakabayashi, K.; Nakano, Y.; Miyachi, H.; Nagasawa, K.; Hashimoto, Y. Ligands with dual vitamin D3-agonistic and androgen-antagonistic activities. Bioorg. Med. Chem. Lett., 2005, 15, 4327-4331 (Pubitemid 41188012)
13. Ma, Y.; Khalifa, B.; Yee, Y. K.; Lu, J.; Memezawa, A.; Savkur, R. S.; Yamamoto, Y.; Chintalacharuvu, S. R.; Yamaoka, K.; Stayrook, K. R.; Bramlett, K. S.; Zeng, Q. Q.; Chandrasekhar, S.; Yu, X. P.; Linebarger, J. H.; Iturria, S. J.; Burris, T. P.; Kato, S.; Chin, W. W.; Nagpal, S. Identification and characterization of noncalcemic, tissue-selective, nonsecosteroidal vitamin D receptor modulators. J. Clin. Invest., 2006, 116, 892-904
14. Shimizu, M.; Miyamoto, Y.; Takaku, H.; Matsuo, M.; Nakabayashi, M.; Masuno, H.; Udagawa, N.; DeLuca, H. F.; Ikura, T.; Ito, N. 2-Substituted-16-ene- 22-thia-1α,25-dihydroxy-26,27- dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation, and crystal structure. Bioorg. Med. Chem., 2008, 16, 6949-6964
15. Inaba, U.; Yoshimoto, N.; Sakamaki, Y.; Nakabayashi, M.; Ikura, T.; Tamamura, H.; Ito, N.; Shimizu, M.; Yamamoto, K. A new class of vitamin D analogues that induce structural rearrangement of the ligand-binding pocket of the receptor. J. Med. Chem., 2009, 52, 1438-1449.
16. Boehm, M. F.; Fitzgerald, P.; Zou, A.; Elgort, M. G.; Bischoff, E. D.; Mere, L.; Mais, D. E.; Bissonnette, R. P.; Heyman, R. A.; Nadzan, A. M.; Reichman, M.; Allegretto, E. A. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25- dihydroxyvitamin D3. Chem. Biol., 1999, 6, 265-275 (Pubitemid 29363177)
17. Polek, T. C.; Murthy, S.; Blutt, S. E.; Boehm, M. F.; Zou, A.; Weigel, N. L.; Allegretto, E. A. Novel nonsecosteroidal vitamin D receptor modulator inhibits the growth of LNCaP xenograft tumors in athymic mice without increased serum calcium. The Prostate, 2001, 49, 224-233. (Pubitemid 33062620)
18. Hosoda, S.; Tanatani, A.; Wakabayashi, K.; Makishima, M.; Imai, K.; Miyachi, H.; Nagasawa, K.; Hashimoto, Y. Ligands with a 3,3- diphenylpentane skeleton for nuclear vitamin D and androgen receptors: Dual activities and metabolic activation. Bioorg. Med. Chem., 2006, 14, 5489-5502. (Pubitemid 43994477)
19. Hakamata, W.; Sato, Y.; Okuda, H.; Honzawa, S.; Saito, N.; Kishimoto, S.; Yamashita, A.; Sugiura, T.; Kittaka, A.; Kurihara, M. (2S,2′R)-Analogue of LG190178 is a major active isomer. Bioorg. Med. Chem. Lett., 2008, 18, 120-123.
20. Kakuda, S.; Okada, K.; Eguchi, H.; Takenouchi, K.; Hakamata, W.; Kurihara, M.; Takimoto-Kamimura, M. Structure of the ligandbinding domain of rat VDR in complex with the nonsecosteroidal vitamin D3 analogue YR301. Acta Cryst., 2008, F64, 970-973.
21. Malloy, P. J.; Pike, J. W.; Feldman, D. The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets. Endocr. Rev., 1999, 20, 156-188. (Pubitemid 29341671)
22. Kristjansson, K.; Rut, A. R.; Hewison, M.; O'Riordan, J. L; Hughes, M. R. Specificity of T cells invading the skin during acute graft-vs.-host disease after semiallogeneic bone marrow transplantation. J. Clin. Invest., 1993, 92, 12-20.
23. Swann, S. L.; Bergh, J. J.; Farach-Carson, M. C.; Koh, J. T. Rational design of vitamin D3 analogues which selectively restore activity to a vitamin D receptor mutant associated with rickets. Org. Lett., 2002, 4, 3863-3866
24. Honzawa, S.; Yamamoto, Y.; Yamashita, A.; Sugiura, T.; Kurihara, M.; Arai, M.; Kato, S.; Kittaka, A. The 2α-(3-hydroxypropyl) group as an active motif in vitamin D3 analogues as agonists of the mutant vitamin D receptor (Arg274Leu). Bioorg. Med. Chem., 2008, 16, 3002-3024. (Pubitemid 351418204)
25. Swan, S. L.; Bergh, J. L.; Farach-Carson, M. C.; Ocasio, C. A.; Koh, J. T. Structure-based design of selective agonists for a ricketsassociated mutant of the vitamin D receptor. J. Am. Chem. Soc., 2002, 124, 13795-13805. (Pubitemid 35378991)
26. Corey, E. J.; Bakshi, R. K.; Shibata, S. Highly enantioselective borane reduction of ketones catalyzed by chiral oxazaborolidines. Mechanism and synthetic implications. J. Am. Chem. Soc., 1987, 109, 5551-5553.
27. Cho, B. T.; Kang, S. K.; Shin, S. H. Application of optically active 1,2-diol monotosylates for synthesis of β-azido and β-amino alcohols with very high enantiomeric purity. Synthesis of enantiopure (R)-octopamine, (R)-tembamide and (R)-aegeline. Tetrahedron Asymmetry, 2002, 13, 1209-1217.